Pattern visual evoked potential as a predictor of occlusion therapy for amblyopia

Area of Science:

• Ophthalmology
• Neuroscience
• Visual Science

Background:

• Amblyopia, a condition of reduced vision, affects millions globally.
• Treatment efficacy for amblyopia, including strabismic, anisometropic, and isometropic types, can vary significantly.
• Predictive markers for treatment response are crucial for optimizing patient care.

Purpose of the Study:

• To determine if pattern visual evoked potential (pVEP) P100 latency predicts treatment outcomes in amblyopia.
• To compare pVEP characteristics between strabismic and anisometropic amblyopia.
• To assess the relationship between initial P100 latency and visual improvement after occlusion therapy or glasses.

Main Methods:

• A retrospective case series of 120 amblyopia patients (strabismic, anisometropic, isometropic) was analyzed.
• Initial pVEP P100 latency was recorded at diagnosis.
• Patients were grouped based on P100 latency (≤120 msec vs. >120 msec) to compare visual improvement after 6 months of treatment.

Main Results:

• No significant difference in mean P100 latency was found between strabismic and non-strabismic amblyopia.
• Patients with P100 latency ≤120 msec showed significantly greater visual improvement (3.69 lines) compared to those with latency >120 msec (2.27 lines).
• Initial P100 latency was significantly related to visual improvement post-treatment.

Conclusions:

• Initial pVEP P100 latency is a significant predictor of visual improvement in amblyopia patients treated with occlusion or glasses.
• Delayed P100 latency may indicate a poorer visual outcome following standard amblyopia therapies.
• pVEP P100 latency does not differ significantly between strabismic and non-strabismic amblyopia types.